Abstract
The inflammatory process plays a key role in neurodegenerative disorder. The inflammatory molecule, 5-lipooxygenase (5-LOX), protein is involved in the pathologic phenotype of AD which includes Aβ amyloid deposition and tau hyperphosphorylation. This study aims to identify the mechanistic role in neuroprotection by 5-LOX inhibitor in neurotoxic SH-SY5Y cell line model by evaluating different cell survival pathway. The neurotoxic SH-SY5Y cells were developed by the treatment of Aβ25-35. The cells were then treated with 5-LOX peptide inhibitor, YWCS to prevent neurotoxicity reported earlier from our lab. The effect of 5-LOX inhibition on cell survival pathways were determined by western blot experiment with different doses of peptide by using polyclonal anti body of p53, anti-Akt and anti-phosphorylated Akt. Immunoprecipitation and mass spectroscopic studies were done to identify the altered proteins appeared on the blot. Over expression of phosphorylated Akt and 3 bands on p53 lane blot other than p53 were observed. Three bands were identified as isoforms of p53 which correspond to p73, Δ133p53 and Δ160p53 in the cells treated only with 80µM of YWCS compare to untreated cells. However, no alteration of total p53 and Akt were observed in treated cells. The results exposed the novel mechanistic pathway of neuroprotection by 5-LOX inhibition is likely to be mediated by DNA DSB repair through p53 isoforms and PI3K/Akt pathway. Our finding has opened a new window in the therapeutic approach for the prevention of AD.
Highlights
Alzhemier’s disease (AD) is the most common cause of dementia in the elderly
The western blot for Akt and p-Akt were carried out to check the effect of YWCS peptide on their expression and phosphorylation status
Our results suggest that the inhibition of 5-LOX
Summary
Alzhemier’s disease (AD) is the most common cause of dementia in the elderly. Due to increasing longevity and the lack of therapy, AD has become a major health problem and imposes substantial social and economic burden worldwide[1]. The inflammatory process plays a key role in neurodegenerative disorder. Lipooxygenase (5-LOX), protein is involved in the pathologic phenotype of AD which includes. Recent research from our lab has proposed the role of 5-LOX peptide inhibitor as neuroprotective molecule for AD[2], provides rescue to neuronal cells from amyloid induced proteotoxic stress/neurotoxicity. The 5-LOX peptide inhibitor reduced γ-secretase expression as well as tau hyperphosphorylation at threonine 181
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.